Published in Health Business Week, September 28th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Novogen Limited.
Report 1: Marshall Edwards, Inc. (NASDAQ:MSHL) announced that it entered into definitive agreements for an approximately US$16.4 million private placement consisting of 5,464,001 shares of common stock at a purchase price of US$3.00 per share. The investors in the transaction also received a warrant to purchase an additional 4 shares of common stock for every block of 10 shares of common stock purchased. Marshall Edwards also issued 62,091 warrants to Blue Trading, LLC, which acted as the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.